title: Direct myocardial revascularization and angiogenesis--how many patients might be eligible?
abstract: This study examines the proportion of patients with ischemic heart disease who may be candidates for the newer modalities of revascularization. A significant proportion (approximately 5%) of patients who undergo coronary angiography at tertiary referral centers may be eligible for newer methods of therapy.
authors.affiliation: Department of Cardiology, The Cleveland Clinic Foundation, Ohio 44195, USA.
authors.forename: D
authors.initials: D
authors.lastname: Mukherjee
authors.forename: D L
authors.initials: DL
authors.lastname: Bhatt
authors.forename: M T
authors.initials: MT
authors.lastname: Roe
authors.forename: V
authors.initials: V
authors.lastname: Patel
authors.forename: S G
authors.initials: SG
authors.lastname: Ellis
mesh_terms: D000368:Aged; D017023:Coronary Angiography; D001026:Coronary Artery Bypass; D003326:Coronary Circulation / Q000502:physiology*; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D016228:Endothelial Growth Factors / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008222:Lymphokines / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D018919:Neovascularization, Physiologic / Q000187:drug effects / Q000502:physiology; D018579:Patient Selection; D011379:Prognosis; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors